BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 20 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,027,000 | -17.8% | 23,800 | -12.0% | 0.00% | 0.0% |
| Q4 2020 | $1,249,000 | +5.5% | 27,037 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $1,184,000 | -7.6% | 27,305 | +12.9% | 0.00% | 0.0% |
| Q2 2020 | $1,282,000 | -44.6% | 24,182 | -76.6% | 0.00% | -66.7% |
| Q1 2020 | $2,314,000 | -49.8% | 103,535 | -67.2% | 0.00% | -25.0% |
| Q4 2019 | $4,612,000 | +107.5% | 315,700 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $2,223,000 | -32.0% | 315,700 | +5.8% | 0.00% | -50.0% |
| Q2 2019 | $3,270,000 | +10.8% | 298,400 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,951,000 | +156.2% | 298,400 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $1,152,000 | -49.6% | 298,400 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $2,286,000 | -16.7% | 298,400 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $2,745,000 | -18.4% | 298,400 | -9.1% | 0.00% | -20.0% |
| Q1 2018 | $3,362,000 | – | 328,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |